Published Dec 20, 2019
Dexcom CEO talks Servers, Control IQ and more
Dexcom CEO Kevin Sayer joins Scott Benner to delve into the pivotal advancements in diabetes technology, from the FDA's approval of Tandem's Control IQ system to partnerships with insulin leaders, while addressing community concerns over a recent CGM data-sharing outage and the company's strategies for future prevention.
Topics covered
Popular Clips
Episode Highlights
Related Episodes
#694 Dexcom CEO chats from ADA 2022
Answers 383 questions#345 Dexcom CEO Returns
Answers 383 questions#116 Dexcom Update with CEO Kevin Sayer
Answers 383 questions
#662 Control IQ Ninja
Answers 383 questions#920 Best of Juicebox: Control IQ Ninja
Answers 383 questions#498 Dexcom G7 Talk With Dexcom CEO Kevin Sayer
Answers 383 questions
#309 Omnipod and Dexcom Updates
Answers 383 questions
#275 Dexcom Pro and COMISAIR
Answers 383 questions
#954 Dexcom COO Jake Leach: G7, G6, Type 2 and your Questions
Answers 383 questions#234 Dexcom CEO Kevin Sayer Returns
Answers 383 questions
#800 Lazy Control IQ Ninja
Answers 383 questions#806 Dexcom G7 Approved By FDA (with Dexcom COO Jake Leach)
Answers 383 questions#158 Dexcom G6 Overview With Dexcom President Kevin Sayer
Answers 383 questions
#194 Dexcom Returns
Answers 383 questions#418 Dexcom G7 Update
Answers 383 questions